Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H B Carter

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
JAMA|April 22, 1992
Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate diseaseH B Carter, J D Pearson, E J Metter, et al.
Urology|March 1, 1997
Percentage of free prostate-specific antigen in sera predicts aggressiveness of prostate cancer a decade before diagnosisH B Carter, A W Partin, A A Luderer, et al.
Urology|May 1, 1994
Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastasesA W Partin, J D Pearson, P K Landis, et al.
The Journal of Urology|November 7, 2001
Plasma selenium level before diagnosis and the risk of prostate cancer developmentJ D Brooks, E J Metter, D W Chan, et al.
The Journal of Urology|April 1, 1990
Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasiaA W Partin, H B Carter, D W Chan, et al.
The Prostate. Supplement|January 1, 1996
Clearance rate of serum-free and total PSA following radical retropubic prostatectomyA W Partin, S Piantadosi, E N Subong, et al.
Urology|December 1, 1996
The role of free/total prostate-specific antigen ratio in the prediction of final pathologic stage for men with clinically localized prostate cancerJ Pannek, E N Subong, K A Jones, et al.
Cancer Research|June 15, 1992
Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate diseaseH B Carter, C H Morrell, J D Pearson, et al.
Prostate Cancer and Prostatic Diseases|April 19, 2017
Longitudinal assessment of urinary PCA3 for predicting prostate cancer grade reclassification in favorable-risk men during active surveillanceJ J Tosoian, H D Patel, M Mamawala, et al.
Urology|December 1, 1996
Multicenter comparison of the diagnostic performance of free prostate-specific antigenR P Thiel, J E Oesterling, K J Wojno, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
JAMA|April 22, 1992
Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate diseaseH B Carter, J D Pearson, E J Metter, et al.
Urology|March 1, 1997
Percentage of free prostate-specific antigen in sera predicts aggressiveness of prostate cancer a decade before diagnosisH B Carter, A W Partin, A A Luderer, et al.
Urology|May 1, 1994
Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastasesA W Partin, J D Pearson, P K Landis, et al.
The Journal of Urology|November 7, 2001
Plasma selenium level before diagnosis and the risk of prostate cancer developmentJ D Brooks, E J Metter, D W Chan, et al.
The Journal of Urology|April 1, 1990
Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasiaA W Partin, H B Carter, D W Chan, et al.
The Prostate. Supplement|January 1, 1996
Clearance rate of serum-free and total PSA following radical retropubic prostatectomyA W Partin, S Piantadosi, E N Subong, et al.
Urology|December 1, 1996
The role of free/total prostate-specific antigen ratio in the prediction of final pathologic stage for men with clinically localized prostate cancerJ Pannek, E N Subong, K A Jones, et al.
Cancer Research|June 15, 1992
Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate diseaseH B Carter, C H Morrell, J D Pearson, et al.
Prostate Cancer and Prostatic Diseases|April 19, 2017
Longitudinal assessment of urinary PCA3 for predicting prostate cancer grade reclassification in favorable-risk men during active surveillanceJ J Tosoian, H D Patel, M Mamawala, et al.
Urology|December 1, 1996
Multicenter comparison of the diagnostic performance of free prostate-specific antigenR P Thiel, J E Oesterling, K J Wojno, et al.
Pageof 10